Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-09

FDA Approved: ACETAZOLAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' supplemental application for acetazolamide, finalizing approval for changes to the approved generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)